Clinical trial
Integrated Studies in Vascular Reactivity and Anaemia Correction Therapy in Endstage Kidney Disease Patients
NCT00226902 is registered in ClinicalTrials.gov with Melbourne Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Integrated Studies in Vascular Reactivity and Anaemia Correction Therapy in Endstage Kidney Disease Patients
- Lead sponsor
- Melbourne Health
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- September 30, 2013
- Enrollment
- 15
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.